Return On Assets in % of Arbutus Biopharma Corp from Q3 2014 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Arbutus Biopharma Corp quarterly/annual Return On Assets history and change rate from Q3 2014 to Q3 2025.
  • Arbutus Biopharma Corp Return On Assets for the quarter ending 30 Sep 2025 was -37.6 %, a 27% increase year-over-year.
  • Arbutus Biopharma Corp annual Return On Assets for 2024 was -48 %, a 10.6% decline from 2023.
  • Arbutus Biopharma Corp annual Return On Assets for 2023 was -43.4 %, a 33.1% decline from 2022.
  • Arbutus Biopharma Corp annual Return On Assets for 2022 was -32.6 %, a 30.3% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Arbutus Biopharma Corp Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -37.6 +13.9 +27% 01 Jul 2025 30 Sep 2025
Q2 2025 -44.1 +6.2 +12.3% 01 Apr 2025 30 Jun 2025
Q1 2025 -55.8 -8.55 -18.1% 01 Jan 2025 31 Mar 2025
Q4 2024 -48 -4.59 -10.6% 01 Oct 2024 31 Dec 2024
Q3 2024 -51.6 -9.74 -23.3% 01 Jul 2024 30 Sep 2024
Q2 2024 -50.3 -12.3 -32.2% 01 Apr 2024 30 Jun 2024
Q1 2024 -47.2 -12.5 -35.9% 01 Jan 2024 31 Mar 2024
Q4 2023 -43.4 -10.8 -33.1% 01 Oct 2023 31 Dec 2023
Q3 2023 -41.8 -9.82 -30.7% 01 Jul 2023 30 Sep 2023
Q2 2023 -38 -3.78 -11% 01 Apr 2023 30 Jun 2023
Q1 2023 -34.7 +6.01 +14.7% 01 Jan 2023 31 Mar 2023
Q4 2022 -32.6 +14.2 +30.3% 01 Oct 2022 31 Dec 2022
Q3 2022 -32 +17.3 +35.1% 01 Jul 2022 30 Sep 2022
Q2 2022 -34.2 +17.8 +34.2% 01 Apr 2022 30 Jun 2022
Q1 2022 -40.8 +11 +21.3% 01 Jan 2022 31 Mar 2022
Q4 2021 -46.8 +7.63 +14% 01 Oct 2021 31 Dec 2021
Q3 2021 -49.3 +16.1 +24.6% 01 Jul 2021 30 Sep 2021
Q2 2021 -52.1 +75.7 +59.2% 01 Apr 2021 30 Jun 2021
Q1 2021 -51.8 +59.7 +53.6% 01 Jan 2021 31 Mar 2021
Q4 2020 -54.4 +44 +44.7% 01 Oct 2020 31 Dec 2020
Q3 2020 -65.3 +13.6 +17.2% 01 Jul 2020 30 Sep 2020
Q2 2020 -128 -86.9 -213% 01 Apr 2020 30 Jun 2020
Q1 2020 -111 -85.2 -325% 01 Jan 2020 31 Mar 2020
Q4 2019 -98.5 -76.1 -340% 01 Oct 2019 31 Dec 2019
Q3 2019 -78.9 -49.9 -172% 01 Jul 2019 30 Sep 2019
Q2 2019 -40.8 -16.7 -68.9% 01 Apr 2019 30 Jun 2019
Q1 2019 -26.2 +7 +21.1% 01 Jan 2019 31 Mar 2019
Q4 2018 -22.4 +11.4 +33.7% 01 Oct 2018 31 Dec 2018
Q3 2018 -29 +73.8 +71.8% 01 Jul 2018 30 Sep 2018
Q2 2018 -24.2 +59.6 +71.2% 01 Apr 2018 30 Jun 2018
Q1 2018 -33.2 +64.1 +65.9% 01 Jan 2018 31 Mar 2018
Q4 2017 -33.8 +42.1 +55.5% 01 Oct 2017 31 Dec 2017
Q3 2017 -103 -75.1 -271% 01 Jul 2017 30 Sep 2017
Q2 2017 -83.8 -56.8 -210% 01 Apr 2017 30 Jun 2017
Q1 2017 -97.4 -88.4 -990% 01 Jan 2017 31 Mar 2017
Q4 2016 -75.9 -67.7 -830% 01 Oct 2016 31 Dec 2016
Q3 2016 -27.8 -17.4 -169% 01 Jul 2016 30 Sep 2016
Q2 2016 -27 -17.8 -192% 01 Apr 2016 30 Jun 2016
Q1 2016 -8.93 +2.37 +21% 01 Jan 2016 31 Mar 2016
Q4 2015 -8.16 +22.1 +73% 01 Oct 2015 31 Dec 2015
Q3 2015 -10.3 +19.9 +65.8% 01 Jul 2015 30 Sep 2015
Q2 2015 -9.23 01 Apr 2015 30 Jun 2015
Q1 2015 -11.3 01 Jan 2015 31 Mar 2015
Q4 2014 -30.2 01 Oct 2014 31 Dec 2014
Q3 2014 -30.2 01 Jul 2014 30 Sep 2014

Arbutus Biopharma Corp Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -48 -4.59 -10.6% 01 Jan 2024 31 Dec 2024
2023 -43.4 -10.8 -33.1% 01 Jan 2023 31 Dec 2023
2022 -32.6 +14.2 +30.3% 01 Jan 2022 31 Dec 2022
2021 -46.8 +7.63 +14% 01 Jan 2021 31 Dec 2021
2020 -54.4 +44 +44.7% 01 Jan 2020 31 Dec 2020
2019 -98.5 -76.1 -340% 01 Jan 2019 31 Dec 2019
2018 -22.4 +11.4 +33.7% 01 Jan 2018 31 Dec 2018
2017 -33.8 +42.1 +55.5% 01 Jan 2017 31 Dec 2017
2016 -75.9 -67.5 -806% 01 Jan 2016 31 Dec 2016
2015 -8.37 +21.9 +72.3% 01 Jan 2015 31 Dec 2015
2014 -30.2 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.